ES482010A1 - Heterocyclic compound - Google Patents

Heterocyclic compound

Info

Publication number
ES482010A1
ES482010A1 ES482010A ES482010A ES482010A1 ES 482010 A1 ES482010 A1 ES 482010A1 ES 482010 A ES482010 A ES 482010A ES 482010 A ES482010 A ES 482010A ES 482010 A1 ES482010 A1 ES 482010A1
Authority
ES
Spain
Prior art keywords
formula
heterocyclic compound
compounds
symbols
prepared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES482010A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of ES482010A1 publication Critical patent/ES482010A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C07D233/78—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Hydantoin derivatives of the formula I < IMAGE > are prepared by the processes mentioned in Claims 1, 12, 16, 18, 25 and 27. The symbols in the formula I have the meaning indicated in Claim 1. The compounds of the formula I have pharmacological properties which are related to those of the natural prostaglandins.
ES482010A 1976-06-03 1979-06-28 Heterocyclic compound Expired ES482010A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2287776 1976-06-03
GB5034076 1976-12-02
GB1214577 1977-03-23

Publications (1)

Publication Number Publication Date
ES482010A1 true ES482010A1 (en) 1980-08-16

Family

ID=27256793

Family Applications (5)

Application Number Title Priority Date Filing Date
ES459412A Expired ES459412A1 (en) 1976-06-03 1977-06-02 Heterocyclic compound
ES470428A Expired ES470428A1 (en) 1976-06-03 1978-06-01 Heterocyclic compound
ES478156A Expired ES478156A1 (en) 1976-06-03 1979-02-28 Heterocyclic compound
ES482010A Expired ES482010A1 (en) 1976-06-03 1979-06-28 Heterocyclic compound
ES489883A Granted ES489883A0 (en) 1976-06-03 1980-03-25 A METHOD OF PREPARING HETERO-CYCLIC COMPOUNDS DERIVED FROM HYDANTOIN

Family Applications Before (3)

Application Number Title Priority Date Filing Date
ES459412A Expired ES459412A1 (en) 1976-06-03 1977-06-02 Heterocyclic compound
ES470428A Expired ES470428A1 (en) 1976-06-03 1978-06-01 Heterocyclic compound
ES478156A Expired ES478156A1 (en) 1976-06-03 1979-02-28 Heterocyclic compound

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES489883A Granted ES489883A0 (en) 1976-06-03 1980-03-25 A METHOD OF PREPARING HETERO-CYCLIC COMPOUNDS DERIVED FROM HYDANTOIN

Country Status (12)

Country Link
JP (1) JPS52151168A (en)
CA (1) CA1176261A (en)
CH (3) CH645631A5 (en)
DE (1) DE2724948A1 (en)
DK (1) DK244577A (en)
ES (5) ES459412A1 (en)
FI (1) FI71930C (en)
FR (1) FR2362839A1 (en)
HU (1) HU183046B (en)
NL (1) NL7706064A (en)
NZ (1) NZ184281A (en)
SE (2) SE446336B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1602188A (en) * 1977-12-01 1981-11-11 Wellcome Found Hydantoin derivatives
AU527959B2 (en) * 1977-09-05 1983-03-31 Wellcome Foundation Limited, The Hydantoin derivatives
DK543178A (en) * 1977-12-01 1979-06-02 Wellcome Found THIODYDANTOIN DERIVATIVES
DE2963795D1 (en) * 1978-01-23 1982-11-11 Beecham Group Plc Hydantoins and thiohydantoins, method for their preparation and pharmaceutical compositions containing them
EP0004723A1 (en) * 1978-03-30 1979-10-17 Beecham Group Plc Deoxyhydantoins, processes for their preparation and pharmaceutical compositions containing them
GB1599740A (en) * 1978-05-31 1981-10-07 Wellcome Found Hydantoin derivatives
AU4778279A (en) * 1978-06-15 1979-12-20 Beecham Group Limited Prostaglandin analogues
IL57504A0 (en) * 1978-06-15 1979-10-31 Beecham Group Ltd Prostagandin analogues,their preparation and pharmaceutical compositions containing
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
EP0007180B1 (en) * 1978-06-15 1983-03-30 Beecham Group Plc Prostaglandin analogue triazole derivatives, processes for their preparation and a pharmaceutical composition containing them
IL59065A0 (en) * 1979-01-18 1980-05-30 Beecham Group Ltd Hydantoin derivatives,their preparation pharmaceutical compositons containing them
JPS55151569A (en) * 1979-05-09 1980-11-26 Wellcome Found Optically active heterocyclic compounds* their synthesis and medical blend containing them
US4684735A (en) * 1985-07-01 1987-08-04 Stauffer Chemical Company Promotion of raney nickel hydrogenation catalyst
JP3022878U (en) * 1995-08-18 1996-04-02 有限会社春江加工 Case for mini discs
MXPA04005123A (en) * 2001-11-30 2005-02-17 Lilly Co Eli Peroxisome proliferator activated receptor agonists.
CA2528179C (en) * 2003-06-06 2013-10-22 Allergan, Inc. Piperidinyl prostaglandin e analogs
US7179820B2 (en) * 2003-06-06 2007-02-20 Allergan, Inc. Piperidinyl prostaglandin E analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1524818A (en) * 1974-11-29 1978-09-13 Beecham Group Ltd 12-azaprostaglandins

Also Published As

Publication number Publication date
ES459412A1 (en) 1978-11-01
FI71930C (en) 1987-03-09
ES8103057A1 (en) 1981-02-16
ES489883A0 (en) 1981-02-16
CH646426A5 (en) 1984-11-30
NL7706064A (en) 1977-12-06
HU183046B (en) 1984-04-28
SE7706428L (en) 1977-12-04
ES470428A1 (en) 1979-09-01
FR2362839B1 (en) 1980-02-01
DK244577A (en) 1977-12-04
DE2724948A1 (en) 1977-12-15
CA1176261A (en) 1984-10-16
CH645631A5 (en) 1984-10-15
JPS52151168A (en) 1977-12-15
NZ184281A (en) 1980-04-28
SE8203161L (en) 1982-05-19
FR2362839A1 (en) 1978-03-24
SE446336B (en) 1986-09-01
ES478156A1 (en) 1979-11-01
JPS6222986B2 (en) 1987-05-20
FI71930B (en) 1986-11-28
FI771763A (en) 1977-12-04
CH647511A5 (en) 1985-01-31

Similar Documents

Publication Publication Date Title
ES482010A1 (en) Heterocyclic compound
JPS5297950A (en) Chalconeether derivatives
ES460040A1 (en) 4-hydroxyphenylalkanolamine derivatives and preparation thereof
ES466851A1 (en) 2-Bromo-6-fluoro-N-(2-imidazolidinylidene)-benzamine and salts thereof and the use to treat hypertension
ES384492A1 (en) Phenylacetylguanidines
ES466590A1 (en) Substituted oxadiazolopyrimidines
GB1471847A (en) Dibenzofuran derivatives
ES472708A1 (en) Bromhexine derivatives and process for making same
JPS51130245A (en) A display body
ES456090A1 (en) 2-amino-or acylamino)-1-sulphonyl-benzoimidazole derivativves
JPS52153947A (en) Dicyclododecyl peroxycarbonate
JPS5273878A (en) Synthesis of 6-carboxyacetyl-3,4-dihydrocarbostyril
JPS52106844A (en) 3-cyanomethylcyclopentanone derivatives
ES465346A1 (en) 2h-imidazole-2-thione derivatives
ES457096A1 (en) Piperonylamine derivatives
ES471208A1 (en) Pyrimidino (1,2a)heterocyclic amide derivatives
JPS5346968A (en) Novel hexadecapeptides
FI772264A (en)
ES8400411A1 (en) Novel sulfimine compound
ES460297A1 (en) 6,11-dihydrodibenzo-(b. e.)-thiepin-11-one-3-aldehyde and 3-acetal derivatives
JPS52118458A (en) Novel methanoanthracene derivatives
ES482304A1 (en) Procedure for the obtaining of new derivatives of mono and dio-oxoquinoxalinas. (Machine-translation by Google Translate, not legally binding)
JPS5321169A (en) Novel lactone derivatives
JPS52116472A (en) Baciferacins
ES457552A1 (en) Amino-alkoxycycloalkanes